US Center for Disease Control and Prevention shows a possible stroke risk for older adults who received an updated Pfizer or a Biontech Covid-19 booster shot. Health officials still say the probability is low to what the agency said in January.

US: CDC looking at potential stroke risk from Pfizer and Biontech shot

BioNTech-Pfizer Covid vaccine sent to China for Germans; 20,000 expatriates to benefit from the vaccine

Pfizer-BioNTech file for emergency use approval for its Covid booster for children aged 5-11

CureVac sues BioNTech over Covid vaccine technology

Pfizer says updated COVID-19 shots boost protection against Omicron

COVID-19: Pfizer and BioNTech begin clinical trial of Omicron-based vaccine

If needed, BioNTech to update its Covid jab within 100 days amid efficiency concerns against Omicron  

COVID-19: US authorises boosters of the Pfizer/BioNTech and Moderna vaccines for all adults

Did Pfizer, BioNTech & Moderna prioritise their Wuhan virus vaccine supplies to rich countries to make billions in profits? A report has claimed that the companies are making $1000 per second in profits from their shots. Palki Sharma tells you more.

Gravitas: 3 companies. 2 Covid-19 vaccines. $34 Billion in profits

The United States has approved Pfizer-BioNTech’s COVID-19 vaccine for children from the ages of 5 to 11, it is a major milestone in country's fight against the pandemic.

United States: CDC approves Pfizer-BioNTech’s COVID-19 vaccine for children

Israel mulls booster shot of Pfizer-BioNTech vaccine to elderly: Official

BioNTech aims to develop mRNA-based malaria vaccine

Taiwan's Foxconn, TSMC reach deal to buy BioNTech COVID-19 vaccine

TSMC is in the process of signing deal to buy COVID-19 vaccines from BioNTech

Pfizer and BioNTech have announced that they would seek the FDA's approval for the third dose of their COVID-19 vaccine to boost its efficacy, as the Delta variant is increasingly becoming a global dominant.

Pfizer-BioNTech to seek FDA approval for third dose of COVID-19 vaccine

US approves Pfizer-BioNTech's Covid vaccine for children aged 12-15

Vaccine maker BioNTech says no need to waive patents 

EU seals deal for more 1.8 billion Pfizer/BioNTech Covid vaccine doses

Pfizer, BioNTech seek approval for Covid vaccine for teens

Largest study on Pfizer Covid vaccine says drug offers over 95% protection

BioNTech said that it expected its COVID-19 vaccine, jointly developed with Pfizer, to be available to 12 to 15-year-olds in Europe from June. The German firm's CEO Ugur Sahin asserted that it was 'in the final stretches' of preparing its submission for European regulatory approval.

BioNTech eyes COVID-19 vaccine for 12-15-year-olds from June in Europe

BioNTech eyes Covid vaccine for 12-15 year olds from June in Europe

BioNTech founder 'confident' its Covid vaccine willl work against strain first found in India

The US National Institute of Health has said that it has begun a study to look at why some people suffered serious allergic reactions shortly after receiving the Pfizer-BioNTech and Moderna COVID-19 vaccines.

US begins study on COVID-19 vaccine side-effects

biontech

Biontech, News on Biontech, stories on Biontech, articles on Biontech, Biontech stories at Wion, Biontech news, Biontech latest news